These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37066307)

  • 21. Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression.
    Kuçi Z; Seiberth J; Latifi-Pupovci H; Wehner S; Stein S; Grez M; Bönig H; Köhl U; Klingebiel T; Bader P; Kuçi S
    Haematologica; 2013 Oct; 98(10):1609-16. PubMed ID: 23975178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.
    Roversi FM; Lopes MR; Machado-Neto JA; Longhini AL; Duarte Ada S; Baratti MO; Palodetto B; Corrocher FA; Pericole FV; Campos Pde M; Favaro P; Traina F; Saad ST
    Stem Cells Dev; 2014 May; 23(10):1109-20. PubMed ID: 24410667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More Human BM-MSC With Similar Subpopulation Composition and Functional Characteristics Can Be Produced With a GMP-Compatible Fabric Filter System Compared to Density Gradient Technique.
    Spohn G; Witte AS; Kretschmer A; Seifried E; Schäfer R
    Front Cell Dev Biol; 2021; 9():638798. PubMed ID: 33869188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells.
    Jones E; English A; Churchman SM; Kouroupis D; Boxall SA; Kinsey S; Giannoudis PG; Emery P; McGonagle D
    Arthritis Rheum; 2010 Jul; 62(7):1944-54. PubMed ID: 20222109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic characterization of distinct human bone marrow-derived MSC subsets.
    Bühring HJ; Treml S; Cerabona F; de Zwart P; Kanz L; Sobiesiak M
    Ann N Y Acad Sci; 2009 Sep; 1176():124-34. PubMed ID: 19796240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
    Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.
    Medyouf H; Mossner M; Jann JC; Nolte F; Raffel S; Herrmann C; Lier A; Eisen C; Nowak V; Zens B; Müdder K; Klein C; Obländer J; Fey S; Vogler J; Fabarius A; Riedl E; Roehl H; Kohlmann A; Staller M; Haferlach C; Müller N; John T; Platzbecker U; Metzgeroth G; Hofmann WK; Trumpp A; Nowak D
    Cell Stem Cell; 2014 Jun; 14(6):824-37. PubMed ID: 24704494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
    Jin HJ; Kwon JH; Kim M; Bae YK; Choi SJ; Oh W; Yang YS; Jeon HB
    Stem Cells Transl Med; 2016 Apr; 5(4):427-39. PubMed ID: 26941359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics.
    Rodrigues ES; de Macedo MD; Pinto MT; Orellana MD; Rocha Junior MC; de Magalhães DA; Tanaka Y; Takayanagui OM; Covas DT; Kashima S
    Virology; 2014 Jan; 449():190-9. PubMed ID: 24418552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the role of the microenvironment in MDS?
    Calvi LM; Li AJ; Becker MW
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101113. PubMed ID: 31779976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes.
    Bandara WMMS; Rathnayake AJIS; Neththikumara NF; Goonasekera HWW; Dissanayake VHW
    Blood Cells Mol Dis; 2021 May; 88():102535. PubMed ID: 33461003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia.
    Lu S; Ge M; Zheng Y; Li J; Feng X; Feng S; Huang J; Feng Y; Yang D; Shi J; Chen F; Han Z
    Stem Cell Res Ther; 2017 Aug; 8(1):178. PubMed ID: 28764810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of Mesenchymal Stromal Cells in Myelodysplastic Syndrome-with Multilineage Dysplasia (MDS-MLD).
    Abbas S; Kumar S; Srivastava VM; Therese M M; Nair SC; Abraham A; Mathews V; George B; Srivastava A
    Indian J Hematol Blood Transfus; 2019 Apr; 35(2):223-232. PubMed ID: 30988556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zheng L; Zhang L; Guo Y; Xu X; Liu Z; Yan Z; Fu R
    Front Immunol; 2022; 13():1078421. PubMed ID: 36569863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
    Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
    Elife; 2023 Jan; 12():. PubMed ID: 36629404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells.
    Luo B; Dong F; Qin T; Zhang Q; Bai H; Wang J; Jia Y; Ma S; Jiang E; Cheng T; Xiao Z; Ema H
    Exp Hematol Oncol; 2022 May; 11(1):28. PubMed ID: 35578364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes].
    Song LX; Guo J; He Q; Yang LP; Gu SC; Zhang Z; Zhang X; Wu LY; Li X; Chang CK
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):127-32. PubMed ID: 23611219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of primary bone marrow mesenchymal stromal cells.
    Li H; Ghazanfari R; Zacharaki D; Lim HC; Scheding S
    Ann N Y Acad Sci; 2016 Apr; 1370(1):109-18. PubMed ID: 27270495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.